Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Douglas L. Jennings"'
Autor:
Brent N. Reed, Robert J. DiDomenico, J. Erin Allender, James C. Coons, Jenna F. Cox, Daniel Johnson, Carrie S. Oliphant, Douglas L. Jennings
Publikováno v:
Journal of Interventional Cardiology, Vol 2019 (2019)
Objectives. To characterize anticoagulation practices with the Impella percutaneous ventricular assist device (pVAD). Background. Managing anticoagulation in patients being supported by the Impella pVAD is made challenging by several unique features
Externí odkaz:
https://doaj.org/article/6526330b72454541a334a629cf3cc1e7
Autor:
Barry Trachtenberg, JENNIFER COWGER, DOUGLAS L. JENNINGS, GILLIAN GRAFTON, RENZO LOYAGA-RENDON, REBECCA COGSWELL, LIVIU KLEIN, PALAK SHAH, MICHAEL KIERNAN, ESTHER VOROVICH
Publikováno v:
Journal of Cardiac Failure. 29:479-502
Publikováno v:
Progress in Transplantation. 33:69-77
Purpose: Malignancy after heart transplantation is associated with poor outcomes. At present, no prediction model exists for any malignancy within the first year after transplant. Methods: We studied adults who underwent heart transplantation include
Autor:
Douglas L Jennings, Bruno Bohn, Amelia Zuver, Duygu Onat, Maureen Gaine, Eugene Royzman, Jonathan Hupf, Danielle Brunjes, Farhana Latif, Susan Restaino, Arthur R Garan, Veli K Topkara, Hiroo Takayama, Koji Takeda, Yoshifumi Naka, Maryjane Farr, Renu Nandakumar, Anne-Catrin Uhlemann, Paolo C Colombo, Ryan T Demmer, Melana Yuzefpolskaya
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233646 (2020)
IntroductionEffective tacrolimus (TAC) dosing is hampered by complex pharmacokinetics and significant patient variability. The gut microbiome, a key mediator of endotoxemia, inflammation and oxidative stress in advanced heart failure (HF) patients, i
Externí odkaz:
https://doaj.org/article/9df5afc892164e3d81d675cf6aa0e342
Autor:
Sabeena Arora, Joseph Radojevic, Ayyaz Ali, Douglas L. Jennings, Jonathan Hammond, Jason Gluck, Abhishek Jaiswal, William L. Baker, Naga Vaishnavi Gadela, A. Scatola, Oisharya Dasgupta, David A. Baran
Publikováno v:
ASAIO Journal. 68:914-919
With the implementation of the new heart transplant (HT) allocation system, patients requiring biventricular support systems have the highest priority, a shorter waitlist time, and a higher frequency of HT. However, the short-term and long-term outco
Autor:
Alberto Pinsino, Matthew R. Carey, Syed Husain, Sumit Mohan, Jai Radhakrishnan, Douglas L. Jennings, Austin S. Nguonly, Annamaria Ladanyi, Lorenzo Braghieri, Koji Takeda, Robert T. Faillace, Gabriel T. Sayer, Nir Uriel, Paolo C. Colombo, Melana Yuzefpolskaya
Publikováno v:
American Journal of Kidney Diseases.
Autor:
Douglas L. Jennings, William L. Baker
Publikováno v:
Pharmacotherapy.
Induction in heart transplant (HT) patients is non-uniform, with center-specific protocols often dictating use and selection of agents according to patient-specific immunologic risk factors. Data regarding the evolution of induction practice patterns
Autor:
Tara Shertel, Nicholas W. Lange, David M. Salerno, Jessica Hedvat, Douglas L. Jennings, Jason Y. Choe, Robert S. Brown, Marcus R. Pereira
Publikováno v:
Transplantation. 106(10)
Autor:
Naga Vaishnavi Gadela, William L. Baker, Sabeena Arora, Douglas L. Jennings, Jonathan Hammond, Ayyaz Ali, David A. Baran, Kathir Balakumaran, A. Scatola, Jason Gluck, Abhishek Jaiswal, Joseph Radojevic
Publikováno v:
Journal of the American Geriatrics Society. 69:2507-2517
OBJECTIVE To examine if older age (>70 years) should be a relative contraindication for heart transplantation, we evaluated the characteristics and outcomes of patients with age ≥70 years listed for heart transplantation; and whether post-transplan
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 41:1024-1032
PURPOSE Effect of pre-transplant amiodarone use on post-heart transplant (HT) survival is not well established. We therefore sought to examine the effect of amiodarone use on post-HT survival. METHODS We stratified adults who underwent HT between Jan